$BFRI
Biofrontera Inc. Stock $bfri

$bfri Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031682 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$10.14M	$4.322M	$4.334M
YoY Change	10.65%	-0.28%	33.27%
Cost Of Revenue	$5.256M	$2.225M	$2.290M
YoY Change	10.12%	-2.84%	126.06%
Gross Profit	$4.888M	$2.097M	$2.044M
YoY Change	11.22%	2.59%	-8.71%
Gross Profit Margin	48.19%	48.52%	47.16%
Selling, General & Admin	$10.21M	$7.765M	$17.25M
YoY Change	10.04%	-54.99%	300.98%
% of Gross Profit	208.84%	370.29%	843.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$125.0K	$131.0K	$134.0K
YoY Change	-4.58%	-2.24%	-52.48%
% of Gross Profit	2.56%	6.25%	6.56%
Operating Expenses	$10.51M	$7.961M	$17.95M
YoY Change	70.11%	-55.65%	307.77%
Operating Profit	-$5.620M	-$3.639M	-$15.91M
YoY Change	215.38%	-77.12%	635.37%
Interest Expense	-$35.00K	$89.00K	-$86.00K
YoY Change	-60.67%	-203.49%	-88.44%
% of Operating Profit
Other Income/Expense, Net	$2.871M	$1.074M	$185.0K
YoY Change	-122.91%	480.54%	12.8%
Pretax Income	-$2.784M	-$2.565M	-$16.01M
YoY Change	-80.8%	-83.97%	447.4%
Income Tax	$1.000K	$1.000K	$6.000K
% Of Pretax Income
Net Earnings	-$2.785M	-$2.566M	-$16.01M
YoY Change	-80.8%	-83.97%	436.42%
Net Earnings / Revenue	-27.45%	-59.37%	-369.45%
Basic Earnings Per Share		-$0.11	-$2.00
Diluted Earnings Per Share	-$0.11	-$0.11	-$2.002M
COMMON SHARES
Basic Shares Outstanding	26.70M shares	23.55M shares	8.000M shares
Diluted Shares Outstanding		22.73M shares	8.000M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.84M	$27.60M	$1.837M
YoY Change	12.74%	1402.61%
Cash & Equivalents	$17.21M	$27.50M	$1.716M
Short-Term Investments	$10.63M	$85.00K	$121.0K
Other Short-Term Assets	$725.0K	$721.0K	$815.0K
YoY Change	-85.01%	-11.53%
Inventory	$7.168M	$12.09M	$5.439M
Prepaid Expenses	$439.0K	$460.0K
Receivables	$7.406M	$5.065M	$2.046M
Other Receivables	$0.00	$3.017M	$0.00
Total Short-Term Assets	$43.14M	$48.49M	$10.14M
YoY Change	-7.07%	378.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$204.0K	$224.0K	$289.0K
YoY Change	-23.6%	-22.49%
Goodwill
YoY Change
Intangibles	$3.032M	$3.136M
YoY Change	-12.12%
Long-Term Investments
YoY Change
Other Assets	$320.0K	$393.0K	$1.373M
YoY Change	19.4%	-71.38%
Total Long-Term Assets	$7.744M	$6.566M	$5.217M
YoY Change	13.92%	25.86%
TOTAL ASSETS
Total Short-Term Assets	$43.14M	$48.49M	$10.14M
Total Long-Term Assets	$7.744M	$6.566M	$5.217M
Total Assets	$50.88M	$55.06M	$15.35M
YoY Change	-4.39%	258.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.278M	$253.0K	$2.029M
YoY Change	94.22%	-87.53%
Accrued Expenses	$10.86M	$9.442M	$8.837M
YoY Change	12.53%	6.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.89M	$17.14M	$11.29M
YoY Change	51.01%	51.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$21.00K	$5.646M	$21.44M
YoY Change	-99.63%	-73.67%
Total Long-Term Liabilities	$21.00K	$5.646M	$21.44M
YoY Change	-99.63%	-73.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.89M	$17.14M	$11.29M
Total Long-Term Liabilities	$21.00K	$5.646M	$21.44M
Total Liabilities	$27.01M	$32.46M	$32.73M
YoY Change	-35.52%	-0.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$79.50M	-$76.70M
YoY Change	0.79%
Common Stock	$27.00K	$23.00K
YoY Change	58.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.88M	$22.60M	-$17.38M
YoY Change
Total Liabilities & Shareholders Equity	$50.88M	$55.06M	$15.35M
YoY Change	-4.39%	258.6%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.785M	-$2.566M	-$16.01M
YoY Change	-80.8%	-83.97%	436.42%
Depreciation, Depletion And Amortization	$125.0K	$131.0K	$134.0K
YoY Change	-4.58%	-2.24%	-52.48%
Cash From Operating Activities	-$8.271M	-$5.941M	-$1.217M
YoY Change	-60.6%	388.17%	-76.07%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	-$1.000K	$1.000K
YoY Change	-111.11%	-200.0%
Acquisitions
YoY Change
Other Investing Activities	-$2.085M	-$3.033M
YoY Change
Cash From Investing Activities	-$2.086M	-$3.034M	$1.000K
YoY Change	23077.78%	-303500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	4.630M	-121.0K
YoY Change	-100.0%	-3926.45%	-101.6%
NET CHANGE
Cash From Operating Activities	-8.271M	-5.941M	-1.217M
Cash From Investing Activities	-2.086M	-3.034M	1.000K
Cash From Financing Activities	0.000	4.630M	-121.0K
Net Change In Cash	-10.36M	-4.345M	-1.337M
YoY Change	-145.37%	224.98%	-154.13%
FREE CASH FLOW
Cash From Operating Activities	-$8.271M	-$5.941M	-$1.217M
Capital Expenditures	$1.000K	-$1.000K	$1.000K
Free Cash Flow	-$8.272M	-$5.940M	-$1.218M
YoY Change	-60.57%	387.68%	-76.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001858685
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges		usd
	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent		usd
	BFRI	Disbursement For Loan Receivable DisbursementForLoanReceivable		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	BFRI	Deferred Offering Costs Included In Accrued Expenses And Other Liabilities DeferredOfferingCostsIncludedInAccruedExpensesAndOtherLiabilities		usd
	BFRI	Noncash Purchase Of Fixed Assets Included In Accounts Payable And Related Party Payable NoncashPurchaseOfFixedAssetsIncludedInAccountsPayableAndRelatedPartyPayable		usd
	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity		usd
CY2021Q4	BFRI	Loan Receivable Short Term LoanReceivableShortTerm		usd
CY2022Q3	BFRI	Receivable For Common Stock Warrants Proceeds ReceivableForCommonStockWarrantsProceeds		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2021Q3	us-gaap	Interest Income Related Party InterestIncomeRelatedParty		usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty		usd
CY2022Q3	BFRI	Reimbursed Costs ReimbursedCosts		usd
	BFRI	Reimbursed Costs ReimbursedCosts		usd
CY2022Q3	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits		shares
CY2021Q3	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits		shares
	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits		shares
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40943
	dei	Entity Registrant Name EntityRegistrantName	Biofrontera Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3765675
	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Presential Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 330
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	City Area Code CityAreaCode	(781)
	dei	Local Phone Number LocalPhoneNumber	245-1325
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26699002	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27518000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24545000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	1562000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3784000	usd
CY2022Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3503000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	8647000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	12087000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4458000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3823000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4987000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	48493000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	46421000	usd
CY2022Q3	us-gaap	Accounts Receivable Related Parties Noncurrent AccountsReceivableRelatedPartiesNoncurrent	2813000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Noncurrent AccountsReceivableRelatedPartiesNoncurrent	2813000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	224000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3136000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3450000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	393000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	268000	usd
CY2022Q3	us-gaap	Assets Assets	55059000	usd
CY2021Q4	us-gaap	Assets Assets	53219000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	253000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	658000	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4206000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	282000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3242000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3242000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9442000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9654000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17143000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13836000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5711000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9542000	usd
CY2022Q3	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	3964000	usd
CY2021Q4	BFRI	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	12854000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5646000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5649000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	32464000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	41881000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23550960	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23550960	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17104749	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17104749	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99306000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90200000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76734000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78879000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	22595000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	11338000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55059000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53219000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4322000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4334000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18530000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14932000	usd
CY2022Q3	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	2127000	usd
CY2021Q3	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	2249000	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	9504000	usd
	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	7630000	usd
CY2022Q3	BFRI	Cost Of Revenues CostOfRevenues	98000	usd
CY2021Q3	BFRI	Cost Of Revenues CostOfRevenues	41000	usd
	BFRI	Cost Of Revenues CostOfRevenues	425000	usd
	BFRI	Cost Of Revenues CostOfRevenues	339000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7765000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17090000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25050000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27412000	usd
CY2022Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	171000	usd
CY2021Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	160000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	612000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	520000	usd
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	199000	usd
	us-gaap	Restructuring Charges RestructuringCharges	654000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2200000	usd
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	700000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4100000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1698000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	7961000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	20439000	usd
	us-gaap	Operating Expenses OperatingExpenses	31491000	usd
	us-gaap	Operating Expenses OperatingExpenses	38253000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3639000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16105000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12961000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23321000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1185000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-15267000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-89000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-86000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-160000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-255000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	185000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	419000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1074000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15137000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	164000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2565000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16006000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2176000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23157000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2566000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16012000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2145000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23208000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.90
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.90
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22725821	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19560351	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22725821	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19605014	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17233000	usd
CY2022Q3	BFRI	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	2841000	usd
CY2022Q3	BFRI	Stock Issued During Period Value Exercise Of Pipe Warrants StockIssuedDuringPeriodValueExerciseOfPipeWarrants	4686000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	401000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2566000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	22595000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	11338000	usd
	BFRI	Stock Issued During Period Value Private Placement Offering StockIssuedDuringPeriodValuePrivatePlacementOffering	116000	usd
	BFRI	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	2841000	usd
	BFRI	Stock Issued During Period Value Exercise Of Pipe Warrants StockIssuedDuringPeriodValueExerciseOfPipeWarrants	4686000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1469000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2145000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	22595000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1368000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16012000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-17380000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5828000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23208000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-17380000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2145000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23208000	usd
	us-gaap	Depreciation Depreciation	80000	usd
	us-gaap	Depreciation Depreciation	95000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	314000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	314000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	4100000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-1698000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-15267000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1469000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	100000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	31000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	36000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	268000	usd
	BFRI	Noncash Interest Expense NoncashInterestExpense	268000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2111000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1210000	usd
	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	-5145000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-4121000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-234000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7728000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1613000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	3519000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	308000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-216000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	11676000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7928000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5725000	usd
	BFRI	Disbursement For Loan Receivable DisbursementForLoanReceivable	3033000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3070000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	638000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9391000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4630000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14021000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-638000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3023000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6365000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24742000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8278000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27765000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1913000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9000	usd
	BFRI	Deferred Offering Costs Included In Accrued Expenses And Other Liabilities DeferredOfferingCostsIncludedInAccruedExpensesAndOtherLiabilities	460000	usd
	BFRI	Noncash Purchase Of Fixed Assets Included In Accounts Payable And Related Party Payable NoncashPurchaseOfFixedAssetsIncludedInAccountsPayableAndRelatedPartyPayable	13000	usd
	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	6840000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27500000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24500000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13000000.0	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5700000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76700000	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5600000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zz08Crr7RyT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zC4aQSwxuNc1">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions by management that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities, as reported on the balance sheet date, and the reported amounts of revenues and expenses arising during the reporting period. The main areas in which assumptions, estimates and the exercising of judgment are appropriate relate to, valuation allowances for receivables and inventory, valuation of contingent consideration and warrant liabilities, realization of intangible and other long-lived assets, product sales allowances and reserves, share-based payments and income taxes including deferred tax assets and liabilities. Estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances. They are continuously reviewed but may vary from the actual values.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2100000	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	6200000	usd
CY2022Q3	BFRI	Startup Cost Financing StartupCostFinancing	7300000	usd
CY2021Q4	BFRI	Startup Cost Financing StartupCostFinancing	7300000	usd
CY2022Q3	BFRI	Contract Asset ContractAsset	-447000	usd
CY2021Q4	BFRI	Contract Asset ContractAsset	-716000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	8953000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	12784000	usd
CY2020Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	327000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	338000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	523000	usd
CY2021Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	142000	usd
CY2020Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	7602000	usd
	BFRI	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	1698000	usd
CY2021Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	9300000	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	6200000	usd
	BFRI	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	-4100000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2100000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.66
CY2022Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2000	usd
CY2021Q4	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	12854000	usd
	BFRI	Fair Value Warrant Issuance Of New Derivative Liabilities FairValueWarrantIssuanceOfNewDerivativeLiabilities	13217000	usd
	BFRI	Fair Value Warrant Exercise Of Derivative Liabilities FairValueWarrantExerciseOfDerivativeLiabilities	-6840000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-15267000	usd
CY2022Q3	BFRI	Fair Value Warrant Liability Purchase Warrant FairValueWarrantLiabilityPurchaseWarrant	3964000	usd
CY2021Q4	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	246000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Provision Related To Current Period RevenueFromContractWithCustomerAllowancesAndReservesProvisionRelatedToCurrentPeriod	691000	usd
	BFRI	Revenue From Contract With Customer Allowances And Reserves Credit Payments Made During Period RevenueFromContractWithCustomerAllowancesAndReservesCreditPaymentsMadeDuringPeriod	577000	usd
CY2022Q3	BFRI	Revenue From Contract With Customer Allowances And Reserves RevenueFromContractWithCustomerAllowancesAndReserves	360000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2022Q3	BFRI	Legal Settlements Receivable Percentage LegalSettlementsReceivablePercentage	0.50	pure
CY2022Q3	us-gaap	Other Receivables OtherReceivables	200000	usd
CY2022Q3	BFRI	Loan Receivable Short Term LoanReceivableShortTerm	3017000	usd
CY2021Q4	BFRI	Receivable For Common Stock Warrants Proceeds ReceivableForCommonStockWarrantsProceeds	3258000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	460000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	824000	usd
CY2022Q3	us-gaap	Deposit Assets DepositAssets	85000	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	149000	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	261000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	756000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3823000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4987000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	709000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	673000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	485000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	406000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	224000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267000	usd
	us-gaap	Depreciation Depreciation	100000	usd
	us-gaap	Depreciation Depreciation	100000	usd
CY2022Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2021Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1464000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1150000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3136000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3450000	usd
CY2022Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	4600000	usd
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2022Q3	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2021Q4	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27518000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24545000	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	47000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	47000	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	200000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	150000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27765000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24742000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2243000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2384000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	676000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	570000	usd
CY2022Q3	BFRI	Accrued Product Revenue Allowances And Reserves AccruedProductRevenueAllowancesAndReserves	360000	usd
CY2021Q4	BFRI	Accrued Product Revenue Allowances And Reserves AccruedProductRevenueAllowancesAndReserves	246000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	538000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	829000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9442000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9654000	usd
CY2022Q3	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2021Q4	BFRI	Legal Settlement Expenses LegalSettlementExpenses	5625000	usd
CY2022Q3	BFRI	Other Liability Noncurrent OtherLiabilityNoncurrent	21000	usd
CY2021Q4	BFRI	Other Liability Noncurrent OtherLiabilityNoncurrent	24000	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	5646000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	5649000	usd
CY2022Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	0	usd
CY2021Q3	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	200000	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	500000	usd
CY2022Q3	BFRI	Legal Settlements Receivable Percentage LegalSettlementsReceivablePercentage	0.50	pure
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2021Q3	us-gaap	Restructuring Costs RestructuringCosts	200000	usd
	us-gaap	Restructuring Costs RestructuringCosts	700000	usd
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2857143	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4285715	shares
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4600000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613614000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1290489000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	63946000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.77
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1840157000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y6M7D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	29332000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.61
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y7M17D
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2600000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2022Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	3000	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	10000	usd
CY2022Q3	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	89000	usd
CY2021Q3	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	90000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	268000	usd
	BFRI	Contract Asset Interest Expense ContractAssetInterestExpense	268000	usd
CY2022Q3	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	1000	usd
	us-gaap	Interest Income Related Party InterestIncomeRelatedParty	110000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	2000	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	4000	usd
	us-gaap	Interest Income Other InterestIncomeOther	8000	usd
	us-gaap	Interest Income Other InterestIncomeOther	13000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	89000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	86000	usd
	us-gaap	Interest Expense InterestExpense	160000	usd
	us-gaap	Interest Expense InterestExpense	255000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.90
CY2021Q3	BFRI	Reimbursed Costs ReimbursedCosts	188000	usd
	BFRI	Reimbursed Costs ReimbursedCosts	472000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.00
CY2022Q3	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	-22000	usd
CY2021Q3	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	-3000	usd
	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	30000	usd
	BFRI	Other Nonoperating Income Net OtherNonoperatingIncomeNet	-53000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	185000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	419000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2566000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16012000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2145000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23208000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22725821	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19560351	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8000000	shares
	BFRI	Stock Options And Restricted Stock Units StockOptionsAndRestrictedStockUnits	44663	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22725821	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19605014	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8000000	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.90
CY2022Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	164000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	565000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	541000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	389000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1659000	usd
CY2021Q4	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	the Company entered into a settlement and release agreement with respect to a lawsuit filed March 23, 2018
CY2021Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	22500000	usd
CY2021Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	11300000	usd
	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	aggregate settlement amount, plus interest accrued at a rate equal to the weekly average one-year constant maturity Treasury yield and agreed to pay in three annual installments
CY2022Q3	BFRI	Legal Settlement Liability LegalSettlementLiability	11300000	usd
CY2022Q3	us-gaap	Loss Contingency Receivable LossContingencyReceivable	5600000	usd
	us-gaap	Description Of Nature And Effect Of Significant Changes During Period Affecting Comparability DescriptionOfNatureAndEffectOfSignificantChangesDuringPeriodAffectingComparability	The Company matches 50% of employee contributions up to a maximum of 6% of employees’ salary
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	usd
CY2021Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	usd

Files In Submission

Name	View Source	Status
0001493152-22-031682-index-headers.html	Edgar Link	pending
0001493152-22-031682-index.html	Edgar Link	pending
0001493152-22-031682.txt	Edgar Link	pending
0001493152-22-031682-xbrl.zip	Edgar Link	pending
bfri-20220930.xsd	Edgar Link	pending
bfri-20220930_cal.xml	Edgar Link	unprocessable
bfri-20220930_def.xml	Edgar Link	unprocessable
bfri-20220930_lab.xml	Edgar Link	unprocessable
bfri-20220930_pre.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFRI
Biofrontera Inc. Stock $bfri

2022 Q4 Form 10-Q Financial Statement

#000149315222031682 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI Biofrontera Inc. Stock $bfri

2022 Q4 Form 10-Q Financial Statement

#000149315222031682 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFRI
Biofrontera Inc. Stock $bfri